HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zatebradine slows ectopic ventricular rhythms in canine heart 24 hours after coronary artery ligation.

Abstract
Arrhythmias occur 24 h after occlusion of the left anterior descending (LAD) coronary artery in the canine heart and have been attributed to the abnormal spontaneous activity in subendocardial Purkinje fibers, which are markedly depolarized. The major current underlying normal automaticity in these fibers is i(f). Although the i(f) activation range is generally considered to be more negative than the diastolic membrane potential in these depolarized fibers in infarcts, this activation range has been shown to shift in a positive direction in response to hormonal influences. Thus i(f) could still mediate automaticity in these fibers in infarcts. Furthermore, recent reports indicate that a depolarizing diastolic current, probably i(f), also can be measured in ventricular muscle during abnormal experimental conditions, which may occur during ischemia. To test whether there is a role of i(f) currents in sustaining ventricular ectopy, we administered the selective i(f) channel blocker, zatebradine, 24 h after LAD ligation in canine hearts. We report that intravenous injections of zatebradine (0.25 or 1.0 mg/kg) significantly slow ventricular rhythms (with average reductions of 19 or 26%, respectively). Moreover, because zatebradine also slows sinus nodal rate, it can lead to an increased incidence of ectopic beats. However, during right atrial pacing, when sinus slowing has no effect on ventricular rhythms, capture of ventricular rhythms occurs at lower rates in the presence of zatebradine. The reduction of capture threshold is comparable to the reduction in the rate of the ectopic rhythm. Thus zatebradine eliminated the arrhythmia when the right atrium was paced at the original sinus rate.
AuthorsS M Lasker, D Han, R P Kline
JournalJournal of cardiovascular pharmacology (J Cardiovasc Pharmacol) Vol. 29 Issue 5 Pg. 662-9 (May 1997) ISSN: 0160-2446 [Print] United States
PMID9213210 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Anti-Arrhythmia Agents
  • Benzazepines
  • Cardiotonic Agents
  • zatebradine
Topics
  • Animals
  • Anti-Arrhythmia Agents (administration & dosage, pharmacology)
  • Benzazepines (administration & dosage, pharmacology)
  • Cardiac Pacing, Artificial
  • Cardiotonic Agents (administration & dosage, pharmacology)
  • Coronary Vessels (physiology)
  • Dogs
  • Electrocardiography (drug effects)
  • Electrophysiology
  • Heart Rate (drug effects, physiology)
  • In Vitro Techniques
  • Injections, Intravenous
  • Purkinje Fibers (drug effects, physiology)
  • Ventricular Premature Complexes (physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: